Marcel Mischnik - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marcel Mischnik

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Biochemical Journal|April 26, 2022

Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.

The Journal of Biological Chemistry|December 18, 2020

A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.

Journal of Clinical Medicine|February 15, 2022

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical EvidenceThomas Gentinetta, John D Belcher, Valérie Brügger-Verdon, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Biochemical Journal|April 26, 2022

Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.

The Journal of Biological Chemistry|December 18, 2020

A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialSandra Wymann, Yun Dai, Anup G Nair, et al.

Journal of Clinical Medicine|February 15, 2022

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical EvidenceThomas Gentinetta, John D Belcher, Valérie Brügger-Verdon, et al.

Pageof 2